Our study discovered a novel duo of proteins reticulocalbin-1, and sideroflexin-4 that showed potential as valuable future biomarkers for the diagnosis and clinical management of COPD exacerbations. The gene discussed is SFXN4; the disease is chronic obstructive pulmonary disease.